Blood Pressure After Endovascular Thrombectomy and Outcomes in Patients With Acute Ischemic Stroke Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • BACKGROUND AND OBJECTIVES: To explore the association between blood pressure (BP) levels after endovascular thrombectomy (EVT) and the clinical outcomes of patients with acute ischemic stroke (AIS) patients with large vessel occlusion (LVO). METHODS: A study was eligible if it enrolled patients with AIS >18 years of age with an LVO treated with either successful or unsuccessful EVT and provided either individual or mean 24-hour systolic BP values after the end of the EVT procedure. Individual patient data from all studies were analyzed with a generalized linear mixed-effects model. RESULTS: A total of 5,874 patients (mean age 69 ± 14 years; 50% women; median NIH Stroke Scale score on admission 16) from 7 published studies were included. Increasing mean systolic BP levels per 10 mm Hg during the first 24 hours after the end of the EVT were associated with a lower odds of functional improvement (unadjusted common odds ratio [OR] 0.82, 95% confidence interval [CI] 0.80-0.85; adjusted common OR 0.88, 95% CI 0.84-0.93) and modified Rankin Scale score ≤2 (unadjusted OR 0.82, 95% CI 0.79-0.85; adjusted OR 0.87, 95% CI 0.82-0.93) and a higher odds of all-cause mortality (unadjusted OR 1.18, 95% CI 1.13-1.24; adjusted OR 1.15, 95% CI 1.06-1.23) at 3 months. Higher 24-hour mean systolic BP levels were also associated with an increased likelihood of early neurologic deterioration (unadjusted OR 1.14, 95% CI 1.07-1.21; adjusted OR 1.14, 95% CI 1.03-1.24) and a higher odds of symptomatic intracranial hemorrhage (unadjusted OR 1.20, 95% CI 1.09-1.29; adjusted OR 1.20, 95% CI 1.03-1.38) after EVT. DISCUSSION: Increased mean systolic BP levels in the first 24 hours after EVT are independently associated with a higher odds of symptomatic intracranial hemorrhage, early neurologic deterioration, 3-month mortality, and worse 3-month functional outcomes.

authors

  • Katsanos, Aristeidis H
  • Malhotra, Konark
  • Ahmed, Niaz
  • Seitidis, Georgios
  • Mistry, Eva A
  • Mavridis, Dimitris
  • Kim, Joon-Tae
  • Veroniki, Areti Angeliki
  • Maier, Ilko
  • Matusevicius, Marius
  • Khatri, Pooja
  • Anadani, Mohammad
  • Goyal, Nitin
  • Arthur, Adam S
  • Sarraj, Amrou
  • Yaghi, Shadi
  • Shoamanesh, Ashkan
  • Catanese, Luciana
  • Kantzanou, Maria
  • Psaltopoulou, Theodora
  • Rentzos, Alexandros
  • Psychogios, Marios
  • Van Adel, Brian
  • Spiotta, Alejandro M
  • Sandset, Else Charlotte
  • de Havenon, Adam
  • Alexandrov, Andrei V
  • Petersen, Nils H
  • Tsivgoulis, Georgios

publication date

  • January 18, 2022